Higher expression of Cp2E1 and Sult1A1 and Sult1A2 in tumors correlated with better survival in breast cancer patients (Figure 7 and Figure 8, Table 1, Table 2 and Table 3). Here, SULT1A1 is linked to breast carcinoma.